ClinConnect ClinConnect Logo
Search / Trial NCT06245499

Aging Brain Care Virtual Program

Launched by INDIANA UNIVERSITY · Jan 30, 2024

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Telehealth Virtual Intervention Aging Brain Care

ClinConnect Summary

The Aging Brain Care Virtual Program is a clinical trial designed to support individuals aged 65 and older who have dementia, including Alzheimer's disease. This program will help patients and their caregivers through regular virtual visits with specially trained nurses or social workers. For the first three months, caregivers will meet monthly, and then every few months depending on the needs of the patient. During these visits, the care team will assess the needs of both the patient and caregiver and provide tailored support to manage issues like behavioral symptoms of dementia, caregiver stress, medication management, and planning for future care.

To be eligible for this program, patients must be 65 or older, have visited their primary care doctor in the last 14 months, and have a diagnosis of Alzheimer's disease or related dementias. Caregivers who want to participate should be at least 18 years old, able to communicate in English, and have access to a phone or computer for virtual meetings. It's important to note that individuals living in a nursing home or those in hospice care cannot join the study. This program offers a unique opportunity for caregivers and patients to receive ongoing support in a convenient virtual format.

Gender

ALL

Eligibility criteria

  • Patient Inclusion Criteria:
  • 65 and older,
  • active primary care patient (visit in past 14 months),
  • diagnosis of Alzheimer's disease and related dementias (ADRD) based on ICD criteria in primary care problems list.
  • Patient Exclusion Criteria:
  • enrolled in hospice at the study start (study screening)or
  • living in a long term care nursing facility.
  • Care Partners Inclusion Criteria:
  • 18 and older,
  • able to access a phone or computer for intervention delivery in English, and
  • identified in the EMR as the emergency contact or as the primary care partner.
  • Care Partners Exclusion Criteria:
  • - Individuals who decline to participate in the ABCV intervention

About Indiana University

Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.

Locations

Indianapolis, Indiana, United States

Patients applied

0 patients applied

Trial Officials

Alexia M Torke, MD, MS

Principal Investigator

Regenstrief Institute, Inc.

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported